Table 1 Socio-demographic and clinical characteristics of patients at the baseline study visit in the enrolled (safety) population (N = 88)
Lactulose | PEG 4000 | p | |
|---|---|---|---|
(N = 44) | (N = 44) | ||
Gender, n (%) | |||
Boys | 24 (54.6%) | 26 (59.1%) | 0.83 |
Girls | 20 (45.5%) | 18 (40.9%) | (χ2 test) |
Age, years | |||
Mean ± SD | 1.98 ± 0.52 | 1.99 ± 0.50 | 0.83 |
Median [range] | 2.0 [1–3] | 2.0 [1–3] | (Student’s t-test) |
Duration of chronic constipation (weeks) | |||
Mean ± SD | 44.4 ± 28.8 | 43.2 ± 21.8 | 0.73 |
Median [range] | 36 [8–116] | 40 [10–104] | (Wilcoxon test) |
Previous treatment for chronic constipation | 26 (59.1%) | 27 (61.4%) | 0.99 (χ2 test) |